Probiotic Use in a Randomized Controlled Trial to Prevent Sepsis and/or Necrotizing Enterocolitis in Low-Birth-Weight Infants

Neonatal sepsis is a major problem throughout the world. Early detection of neonatal difficult because first signs this disease may be minimal, especially in preterm infants. The clinical are similar to those non-infectious processes. Definitive blood culture results not being immediately available prove detrimental. As result, many babies evaluated and treated for presumed with parenteral antibiotics while awaiting microbial isolation. This study was undertaken evaluate efficacy probiotics prevention Late onset or NEC low-birth-weight babies.